Login / Signup

Transcriptomic definition of molecular subgroups of small round cell sarcomas.

Sarah WatsonVirginie PerrinDelphine GuillemotStephanie ReynaudJean-Michel CoindreMarie KaranianJean-Marc GuinebretièrePaul FreneauxFrançois Le LoarerMegane BouvetLouise Galmiche-RollandFrédérique LarousserieElisabeth LongchamptDominique Ranchere-VinceGaelle PierronOlivier DelattreFranck Tirode
Published in: The Journal of pathology (2018)
Sarcoma represents a highly heterogeneous group of tumours. We report here the first unbiased and systematic search for gene fusions combined with unsupervised expression analysis of a series of 184 small round cell sarcomas. Fusion genes were detected in 59% of samples, with half of them being observed recurrently. We identified biologically homogeneous groups of tumours such as the CIC-fused (to DUX4, FOXO4 or NUTM1) and BCOR-rearranged (BCOR-CCNB3, BCOR-MAML3, ZC3H7B-BCOR, and BCOR internal duplication) tumour groups. VGLL2-fused tumours represented a more biologically and pathologically heterogeneous group. This study also refined the characteristics of some entities such as EWSR1-PATZ1 spindle cell sarcoma or FUS-NFATC2 bone tumours that are different from EWSR1-NFATC2 tumours and transcriptionally resemble CIC-fused tumour entities. We also describe a completely novel group of epithelioid and spindle-cell rhabdomyosarcomas characterized by EWSR1- or FUS-TFCP2 fusions. Finally, expression data identified some potentially new therapeutic targets or pathways. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Keyphrases